Fundz
New|Fundz now works inside Claude2 min

Discover more near‑term opportunities with better event intelligence.

Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Jasper Therapeutics Appoints Interim Executives Following CFO Resignation

PUBLIC · JSPRSep 28, 2026

Position

Principal

Company

Jasper Therapeutics

Rick Ruiz
Redwood CityBiotechnologyHealth CareTherapeutics

Description

On September 28, 2026, Jasper Therapeutics appointed new interim officers following the resignation of Herb Cross. Jeet Mahal takes on the role of interim Principal Financial Officer, while Rick Ruiz steps in as interim Principal Accounting Officer. Matthew Ros has been appointed as the interim Corporate Secretary, effective immediately following Mr

Company Information

Company

Jasper Therapeutics

Location

Redwood City, California, United States

About

Our mission is to make safer and potentially curative therapy possible for more patients in need. We are bringing together a team of biotech veterans, leading academic institutions and a strong syndicate of healthcare-focused investors to achieve our vision of developing new therapies for diseases of mast and stem cells, safer and more effective conditioning for monogenetic diseases and new engineered stem cell therapies. Briquilimab (formerly JSP191) is a targeted anti c-Kit monoclonal antibody designed to deplete diseased mast and stem cells as well as enable safer and more effective curative hematopoietic stem cell transplants and stem cell gene therapies.

Fundz sees it the moment Jasper Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mark
Senior decision-maker at this company
••••••••@••••••••

See Mark's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Jasper Therapeutics's next move

Learn about Strategic plan

Jasper Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.